IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia.

Liu X, Sato N, Yabushita T, Li J, Jia Y, Tamura M, Asada S, Fujino T, Fukushima T, Yonezawa T, Tanaka Y, Fukuyama T, Tsuchiya A, Shikata S, Iwamura H, Kinouchi C, Komatsu K, Yamasaki S, Shibata T, Sasaki AT, Schibler J, Wunderlich M, O'Brien E, Mizukawa B, Mulloy JC, Sugiura Y, Takizawa H, Shibata T, Miyake K, Kitamura T, Goyama S

Open source

DOI: 10.15252/emmm.202115631
Published: 2023 Jan 11
Container: EMBO molecular medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.15252/emmm.202115631,
  title = {IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia.},
  author = {Liu X and Sato N and Yabushita T and Li J and Jia Y and Tamura M and Asada S and Fujino T and Fukushima T and Yonezawa T and Tanaka Y and Fukuyama T and Tsuchiya A and Shikata S and Iwamura H and Kinouchi C and Komatsu K and Yamasaki S and Shibata T and Sasaki AT and Schibler J and Wunderlich M and O'Brien E and Mizukawa B and Mulloy JC and Sugiura Y and Takizawa H and Shibata T and Miyake K and Kitamura T and Goyama S},
  year = {2023},
  journal = {EMBO molecular medicine},
  doi = {10.15252/emmm.202115631},
  url = {https://doi.org/10.15252/emmm.202115631}
}

RIS

TY  - JOUR
TI  - IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia.
AU  - Liu X
AU  - Sato N
AU  - Yabushita T
AU  - Li J
AU  - Jia Y
AU  - Tamura M
AU  - Asada S
AU  - Fujino T
AU  - Fukushima T
AU  - Yonezawa T
AU  - Tanaka Y
AU  - Fukuyama T
AU  - Tsuchiya A
AU  - Shikata S
AU  - Iwamura H
AU  - Kinouchi C
AU  - Komatsu K
AU  - Yamasaki S
AU  - Shibata T
AU  - Sasaki AT
AU  - Schibler J
AU  - Wunderlich M
AU  - O'Brien E
AU  - Mizukawa B
AU  - Mulloy JC
AU  - Sugiura Y
AU  - Takizawa H
AU  - Shibata T
AU  - Miyake K
AU  - Kitamura T
AU  - Goyama S
PY  - 2023
JO  - EMBO molecular medicine
DO  - 10.15252/emmm.202115631
UR  - https://doi.org/10.15252/emmm.202115631
ER  -

APA

X, L., N, S., T, Y., J, L., Y, J., M, T., S, A., T, F., T, F., T, Y., Y, T., T, F., A, T., S, S., H, I., C, K., K, K., S, Y., T, S., AT, S., J, S., M, W., E, O., B, M., JC, M., Y, S., H, T., T, S., K, M., T, K., & S, G. (2023). IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia.. EMBO molecular medicine. https://doi.org/10.15252/emmm.202115631

Source records

pubmed · retrieved 2026-09-27T00:18:37.442Z